Qualigen Therapeutics
Carlsbad, California, United States · Biotechnology, Health Care, Therapeutics · 32 employees
Qualigen Therapeutics, Inc. is a small-cap company facing challenges, including the need to regain compliance with NASDAQ's continued listing requirements. The company aims to establish a new strategic direction and enhance shareholder value.
Funding history
- Series seed — $4.5M — Aug 2025
- Funding Round — $5.1M — Nov 2024
Recent signals
- Nov 20, 2025: Qualigen Therapeutics, Inc. Appoints Koti Meka as Executive Director
- Oct 28, 2025: Launched Qualigen Therapeutics Inc. is rebranding as AIxCrypto and launching the BesTrade DeAI Agent, aimed at optimizing trading transactions.
- Oct 06, 2025: Qualigen Therapeutics Appoints Jerry Wang as Co-CEO and Koti Meka as CFO
- Aug 13, 2025: Raised $4.5M in Series seed
- Nov 22, 2024: Raised $5.1M
See plans & pricing → Track Qualigen Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.